Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian population

The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination, however, real world evidence in the In...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Chaturbhuj, Goyal, Pankaj, Agarwal, Amit, Tripathi, Rupal, Dodagoudar, Chandragouda, Baghmar, Saphalta, Sharma, Archana, Batra, Ullas, Talwar, Vineet, Goyal, Sumit, Kumar, Rajeev, Doval, Dinesh Chandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355114/
https://www.ncbi.nlm.nih.gov/pubmed/34376758
http://dx.doi.org/10.1038/s41598-021-95758-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355114/
https://www.ncbi.nlm.nih.gov/pubmed/34376758
http://dx.doi.org/10.1038/s41598-021-95758-1

Ejemplares similares